NewGenIvf Group Limited Announces Closing of $2.5 Million Underwritten Offering
Key Highlights
- ➤NewGenIvf (NIVF) closes $2.5 million underwritten offering
- ➤Offering includes 71,428,570 Class A Ordinary Shares or pre-funded warrants
- ➤Company plans approximately $625,000 to repurchase $584,112 Exchange Note principal
- ➤Proceeds target Nodexus commercialization, reproductive services, strategic investments, and UAE real estate
BANGKOK, Nov. 20, 2026 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (the “Company”), a technology-driven, diversified growth company, today announced the closing of its previously announced firm commitment underwritten offering with gross proceeds to the Company of approximately $2.5 million, before deducting underwriting fees and other offering expenses payable by the Company.
The offering consisted of 71,428,570 Class A Ordinary Shares (or pre-funded warrants to purchase Class A Ordinary Shares in lieu thereof (the “Pre-Funded Warrants”)). At closing, the offering comprised 9,501,148 Class A Ordinary Shares and Pre-Funded Warrants to purchase up to 61,927,422 Class A Ordinary Shares. The offering price per Class A Ordinary Share was $0.035 (or $0.03499 for each Pre-Funded Warrant, which is equal to the offering price per Class A Ordinary Share sold in the offering minus an exercise price of $0.00001 per Pre-Funded Warrant). The Pre-Funded Warrants are immediately exercisable and may be exercised at any time until exercised in full. For each Pre-Funded Warrant sold in the offering, the number of Class A Ordinary Shares in the offering will be decreased on a one-for-one basis.
Get started
Create a free account to read the full story.
